This article is from the WebMD News Archive
Children's Motrin Grape Chewable Recall
May 13, 2004 -- One lot of Children's Motrin grape chewable tablets is being recalled.
Some packages of the kids' Motrin ( ibuprofen) product may mistakenly contain Tylenol 8 Hour extended release geltabs, says the drug's manufacturer, McNeil Pharmaceuticals.
The recalled packages of Children's Motrin all carry the same lot number: Exp. 1/06 JAM108. This number is embossed on the carton end flap and is printed on the bottle label under McNeil's address. This lot was distributed nationwide to wholesale and retail customers between Feb. 5 and April 1, 2004.
It is easy to tell which drug is which:
- Children's Motrin grape chewable tablets are round, purple tablets with the letters MO and the number 50 on the tablet surface.
- Tylenol 8 Hour geltabs are white on one side and red on the other. They are hard, round, gelatin coated, and shiny. They have "8 Hour" printed in blue on one side.
So far, there have been two reports of parents finding the adult Tylenol in the Children's Motrin package. So far, there's no report of a child taking the wrong drug and no report of injury.
A McNeil spokesperson tells WebMD that while all 75,000 packages in the lot are being recalled, few seem to carry the wrong medicine. The manufacturer has recovered thousands of correctly labeled packages from the lot. However, for safety's sake McNeil is continuing to ask parents to return all Children's Motrin packages from this lot.
Anyone who finds one of the packages should call McNeil at 1-800-962-5357.
If you think your child has taken an adult Tylenol capsule instead of a Children's Motrin, call your doctor or local poison control center right away.
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information


